IDH with other targeted gene mutations explored recently in glioblastomas such as telomerase reverse transcriptase (TERT) mutation, epidermal growth factor (EGF) amplification, or chromosomal 10 or 7 gain/loss can be tested using next-generation sequencing (NGS) from the resected tissue. Here, EGF is linked to glioblastoma.